Fang Yuan

Ms. Fang Yuan


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2024 in Cancer Letters
Verified
Journal Article
Open access
XWXing Wang
Xing Wang
XLXiaohong Liu
Xiaohong Liu
RXRuiling Xiao
Ruiling Xiao
FYFang Yuan
Fang Yuan
FZFeihan Zhou
Feihan Zhou
YZYupei Zhao
Yupei Zhao
Cancer cells rewire metabolism to sculpt the immune tumor microenvironment (TME) and propel tumor advancement, which intricately tied to post-translational modifications. Histone lactylation has emerged as a novel player in modulating protein functions, whereas little is known about its pathological role in pancreatic ductal adenocarcinoma (PDAC) progression. Employing a multi-omics approach encompassing bulk and single-cell RNA sequencing, metabolomics, ATAC-seq, and CUT&Tag methodologies, we unveiled the potential of histone lactylation in prognostic prediction, patient stratification and TME characterization. Notably, "LDHA-H4K12la-immuno-genes" axis has introduced a novel node into the regulatory framework of "metabolism-epigenetics-immunity," shedding new light on the landscape of PDAC progression. Furthermore, the heightened interplay between cancer cells and immune counterparts via Nectin-2 in liver metastasis with elevated HLS unraveled a positive feedback loop in driving immune evasion. Simultaneously, immune cells exhibited altered HLS and autonomous functionality across the metastatic cascade. Consequently, the exploration of innovative combination strategies targeting the metabolism-epigenetics-immunity axis holds promise in curbing distant metastasis and improving survival prospects for individuals grappling with challenges of PDAC.

2 February 2024 in Cancer Letters
Verified
Journal Article
Closed access
JRJie Ren
Jie Ren
BRBo Ren
Bo Ren
XLXiaohong Liu
Xiaohong Liu
Ming CuiMing Cui
Ming Cui
FYFang Yuan
Fang Yuan
YZYupei Zhao
Yupei Zhao